One candidate factor, SOX2, was reported to cooperate with LSD1 in lung cancer [69], HER2-positive breast cancer [77], human ovarian teratocarcinoma [17], and pluripotent cancer cells, including teratocarcinoma, embryonic carcinoma, and seminoma CSCs [67]. This evidence concerns the gene KDM1A and lung carcinoma.